Phase 1 Hormone Deficiency Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)

SafetyTolerabilityAdult Growth Hormone Deficiency

Changchun GeneScience Pharmaceutical Co., Ltd.64 enrolled1 locationNCT07016802

Completed

Phase 1

Comparative assessment of the absorption of a generic formulation of (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid tablets against the innovator (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid tablets conducted under fasting conditions in healthy male and female volunteers

(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid is used for the treatment of management of demonstrated thyroid hormone deficiency.

Zenith Technology Corporation Limited24 enrolled1 locationACTRN12620000191998

Completed

Phase 1

A trial comparing ACP-011 administered as a single dose via a syringe and needle versus an auto-injector

Growth failure in children due to Growth Hormone Deficiency

Ascendis Pharma Endocrinology Division A/S26 enrolled1 locationACTRN12617001471370